Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The Ted Rogers Centre for Research actively pursues a wide range of industry partners to help further its mission of optimizing the care of children and adults with heart failure. We welcome collaboration with industry across our tri-focus of clinical care, genetic research, and regenerative medicine.
Why partner with this Centre?
I) World-leading researchers: The Centre is embedded in the health-care and technology hub of Toronto, and its members are experts within three leading institutions. The Hospital for Sick Children is widely regarded as one of the world’s top pediatric health-care centres. University Health Network is Canada’s largest research hospital, with cardiology one of its prime foci. Ranked by scientific paper performance, the University of Toronto is routinely in the top five universities in the world for research.
II) New ideas: The Centre is devoted to health-care innovations that are entirely novel. We conduct and fund research projects that carry the greatest likelihood to translate into clinical practice. Our leadership and advisors ensure we are advancing at all times, testing the true limits of potential for new ideas.
III) Collaborations: Partners gain access to the powers of collaboration and simultaneous expertise in genetics, stem cells and regenerative medicine, and advanced clinical innovations for cardiovascular patients. This tandem approach generates rare and promising opportunities for industry.
IV) Focus on commercialization: We understand that health-care intellectual property stemming from basic or academic research often requires further refinement in order to interest potential investors or companies. The Centre is structured in a way that supports the commercialization of early innovations, with the aim of bringing real products to market.
V) Potential impact: The Centre’s prime focus is heart failure, one of the world’s most burdensome and costliest chronic diseases. Our partners have the opportunity to make meaningful change in the lives of 1 million Canadians with heart failure, and beyond.
Scientific Symposium Partners
Thank you to our partners who sponsored our inaugural scientific symposium in May 2016:
Boehringer Ingelheim and Eli Lilly